GoAI
Get started
Daiken Medical Co., Ltd. logo

Daiken Medical Co., Ltd.

7775.T

JPXHealthcareMedical - Instruments & Supplies

Open in GoAI

Latest quote

¥428

+¥2.00 · +0.47%

Aug 24, 3:30 PM JST

7775.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

Daiken Medical Co., Ltd. is a global developer and provider of healthcare devices and equipment, serving both the Japanese market and international clientele. Its extensive product catalog includes syringe pumps, disposable and portable infusion pumps, endobronchial blocker tubes, a range of suction accessories (containers, connecting tubes, and tips), medical hand washing machines, disposable medical towels, sterilize mats, and wet disinfectant mats. Additionally, the company engages in the trade of other medical apparatus. All its offerings are marketed under the COOPDECH brand. Established in 1968, Daiken Medical Co., Ltd. maintains its headquarters in Izumi, Japan.

Industry
Medical - Instruments & Supplies
Sector
Healthcare
Headquarters
JP
CEO
Keiichi Yamada
Listed since
Mar 12, 2009
Employees
185

Market position

Day range

Current ¥428

52-week range

Current ¥428

Open
¥427
Previous close
¥426
Volume
15K
0.47× average
Average volume
32.02K
Average daily volume
Market cap
12.3B JPY
Beta
0.37
Market reference 1
50-day average
¥422.46
+1.31% above average
200-day average
¥443.76
-3.55% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

P/E (TTM)
14.06×
P/B (TTM)
1.61×
P/S (TTM)
1.2×
Dividend yield
4.67%

Profitability & efficiency

Gross margin
37.70%
Operating margin
11.83%
Net margin
8.55%

Financial health

Debt / equity
0.28×
Altman Z-score
4.94
Piotroski F-score
4 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends47%33%18%4%Gross margin, FY2021: 43.14%Gross margin, FY2022: 38.64%Gross margin, FY2023: 40.84%Gross margin, FY2024: 41.17%Gross margin, FY2025: 38.40%Operating margin, FY2021: 13.48%Operating margin, FY2022: 11.54%Operating margin, FY2023: 14.80%Operating margin, FY2024: 15.19%Operating margin, FY2025: 12.41%Net margin, FY2021: 9.73%Net margin, FY2022: 7.79%Net margin, FY2023: 10.14%Net margin, FY2024: 11.03%Net margin, FY2025: 8.97%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 43.14%. Gross margin FY2022 38.64%. Gross margin FY2023 40.84%. Gross margin FY2024 41.17%. Gross margin FY2025 38.40%. Operating margin FY2021 13.48%. Operating margin FY2022 11.54%. Operating margin FY2023 14.80%. Operating margin FY2024 15.19%. Operating margin FY2025 12.41%. Net margin FY2021 9.73%. Net margin FY2022 7.79%. Net margin FY2023 10.14%. Net margin FY2024 11.03%. Net margin FY2025 8.97%.

Income trends

Revenue

10.29B JPY+3.41%

Operating income

1.28B JPY-15.51%

Net income

922.64M JPY-15.94%
Income trends across reported periods11.25B JPY7.42B JPY3.59B JPY−245.83M JPYRevenue, FY2021: 8.54B JPYRevenue, FY2022: 9.14B JPYRevenue, FY2023: 9.75B JPYRevenue, FY2024: 9.95B JPYRevenue, FY2025: 10.29B JPYOperating income, FY2021: 1.15B JPYOperating income, FY2022: 1.05B JPYOperating income, FY2023: 1.44B JPYOperating income, FY2024: 1.51B JPYOperating income, FY2025: 1.28B JPYNet income, FY2021: 831.06M JPYNet income, FY2022: 712.06M JPYNet income, FY2023: 988.6M JPYNet income, FY2024: 1.1B JPYNet income, FY2025: 922.64M JPYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 8.54B JPY. Revenue FY2022 9.14B JPY. Revenue FY2023 9.75B JPY. Revenue FY2024 9.95B JPY. Revenue FY2025 10.29B JPY. Operating income FY2021 1.15B JPY. Operating income FY2022 1.05B JPY. Operating income FY2023 1.44B JPY. Operating income FY2024 1.51B JPY. Operating income FY2025 1.28B JPY. Net income FY2021 831.06M JPY. Net income FY2022 712.06M JPY. Net income FY2023 988.6M JPY. Net income FY2024 1.1B JPY. Net income FY2025 922.64M JPY.
Metric (JPY)FY2025FY2024FY2023FY2022FY2021
Revenue10.29B JPY9.95B JPY9.75B JPY9.14B JPY8.54B JPY
Cost of goods sold6.34B JPY5.85B JPY5.77B JPY5.61B JPY4.86B JPY
Gross profit3.95B JPY4.1B JPY3.98B JPY3.53B JPY3.68B JPY
Research and development——249M JPY316M JPY382M JPY
Selling, general, and administrative2.67B JPY2.58B JPY2.24B JPY2.11B JPY2.09B JPY
Operating expenses2.67B JPY2.58B JPY2.54B JPY2.48B JPY2.53B JPY
Interest income1.86M JPY————
Interest expense12.34M JPY9.36M JPY4.83M JPY3.97M JPY3.74M JPY
Depreciation and amortization258.04M JPY232.6M JPY214.28M JPY268.86M JPY315.96M JPY
Operating income1.28B JPY1.51B JPY1.44B JPY1.05B JPY1.15B JPY
Net income922.64M JPY1.1B JPY988.6M JPY712.06M JPY831.06M JPY

Company facts updated Aug 24, 2026.

Earnings

Latest EPS result
5.83

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates12.879.395.912.42Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Q4 2024, reported Oct 31, 2024: actual 11.11, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Jan 31, 2025: actual 12.13, estimate —, surprise —, Comparison unavailable. Q2 2025, reported May 15, 2025: actual 4.89, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Jul 31, 2025: actual 7.5, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Oct 31, 2025: actual 10.32, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Jan 30, 2026: actual 11.45, estimate —, surprise —, Comparison unavailable. Q2 2026, reported May 15, 2026: actual 2.85, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Jul 31, 2026: actual 5.83, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates2.95B2.69B2.43B2.17BQ1 '25BeatQ2 '25MissQ3 '25BeatQ4 '25MissQ1 '26MissQ2 '26BeatQ3 '26MissQ4 '26Estimate
Q1 2025, reported Jan 31, 2025: actual 2.75B JPY, estimate 2.69B JPY, surprise +2.34%, Beat. Q2 2025, reported May 15, 2025: actual 2.29B JPY, estimate 2.43B JPY, surprise -5.96%, Miss. Q3 2025, reported Jul 31, 2025: actual 2.5B JPY, estimate 2.48B JPY, surprise +0.69%, Beat. Q4 2025, reported Oct 31, 2025: actual 2.56B JPY, estimate 2.58B JPY, surprise -0.58%, Miss. Q1 2026, reported Jan 30, 2026: actual 2.82B JPY, estimate 2.84B JPY, surprise -0.42%, Miss. Q2 2026, reported May 15, 2026: actual 2.41B JPY, estimate 2.32B JPY, surprise +3.79%, Beat. Q3 2026, reported Jul 31, 2026: actual 2.44B JPY, estimate 2.51B JPY, surprise -2.83%, Miss. Q4 2026, reported Nov 4, 2026: actual —, estimate 2.59B JPY, surprise —, Comparison unavailable.

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

¥23.00

2025 complete year+15.0% since 2021

2026 partial: ¥11.00

* Partial calendar year in the available dividend history.

Corporate action history

DividendUpcoming

Ex-dividend Sep 29, 2026

¥9.00

Semi-Annual

Record Sep 30, 2026 · Payment Sep 29, 2026

DividendUpcoming

Ex-dividend Mar 30, 2027

¥11.00

Semi-Annual

Record Mar 31, 2027 · Payment Mar 30, 2027

Dividend

Ex-dividend Mar 30, 2026

¥11.00

Semi-Annual

Record Mar 31, 2026 · Payment Jun 8, 2026

Dividend

Ex-dividend Sep 29, 2025

¥9.00

Semi-Annual

Record Sep 30, 2025 · Payment Dec 1, 2025

Dividend

Ex-dividend Mar 28, 2025

¥14.00

Semi-Annual

Record Mar 31, 2025 · Payment Jun 2, 2025

Dividend

Ex-dividend Sep 27, 2024

¥9.00

Semi-Annual

Record Sep 30, 2024 · Payment Dec 2, 2024

7775.T peers

Chugai Pharmaceutical Co., Ltd. logo

4519.T

Chugai Pharmaceutical Co., Ltd.

¥6,987

-0.34%

Takeda Pharmaceutical Company Limited logo

4502.T

Takeda Pharmaceutical Company Limited

¥5,797

+0.57%

HOYA Corporation logo

7741.T

HOYA Corporation

¥24,895

0.00%

Otsuka Holdings Co., Ltd. logo

4578.T

Otsuka Holdings Co., Ltd.

¥12,210

+0.12%

Daiichi Sankyo Company, Limited logo

4568.T

Daiichi Sankyo Company, Limited

¥2,858

+0.86%

Astellas Pharma Inc. logo

4503.T

Astellas Pharma Inc.

¥2,406.5

+0.82%

ETFs holding 7775.T

Funds reporting this stock among their holdings, ordered by reported position size.

Dimensional - International Core Equity 2 ETF logoDimensional - International Core Equity 2 ETFDFIC
Market value
45.56K
Weight
0.00%
AUM
15.43B USD
Expense ratio
0.22%
Price / 1D
$39.275-0.34%
Dimensional - International Small Cap ETF logoDimensional - International Small Cap ETFDFIS
Market value
28.94K
Weight
0.00%
AUM
5.91B USD
Expense ratio
0.39%
Price / 1D
$37.43-0.31%
Dimensional World ex U.S. Core Equity 2 ETF logoDimensional World ex U.S. Core Equity 2 ETFDFAX
Market value
16.88K
Weight
0.00%
AUM
12.57B USD
Expense ratio
0.28%
Price / 1D
$37.905-0.67%

Continue in GoAI

Research 7775.T

research.disclaimer